Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
A Torilis japonica Extract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis
Antioxidants (Basel, Switzerland), 2026;15(7)
Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Meta-Analysis
Cureus, 2026;18(6):e111728
Comparative Cardiovascular Outcomes and Safety Profiles of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Trials
Cureus, 2026;18(6):e111723
[The role of obesity and weight reduction in obstructive sleep apnea]
Orvosi hetilap, 2026;167(26):1011-1017
GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns
Journal of pediatric and adolescent gynecology, 2026
Ease of Use, Ease of Learning, and Convenience of the CagriSema Dual-Chamber Pen: Results From a Usability Study in Adults With Overweight, Obesity, or Type 2 Diabetes
Journal of diabetes science and technology, 2026;:19322968261461530
GLP-1 Receptor Agonists and the Ocular Surface: A Narrative Review of Restoration, Remodeling, and Clinical Implications
Ophthalmology and therapy, 2026
Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan
Diabetes, obesity & metabolism, 2026
GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of efficacy, metabolic effects, and safety
Diabetes research and clinical practice, 2026;:113400
The silent rise of self-prescribed semaglutide use among non-obese young adults in the Middle East
Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2026;32(6):394-395
Beyond Weight Loss: Early Real-World Evidence of Semaglutide in Obesity
Medicines (Basel, Switzerland), 2026;13(3)
A Systematic Review and Meta-Analysis Evaluating the Role of GLP-1 Receptor Agonists in Substance Use Disorders
Cureus, 2026;18(6):e111641
Tirzepatide: A turning point in obesity related heart failure with preserved ejection fraction?
JPMA. The Journal of the Pakistan Medical Association;76(6):1001
GLP-1 receptor agonists and Risk of Cardiovascular and Pulmonary Complications in patients with OSA and Type 2 Diabetes Mellitus
Sleep & breathing = Schlaf & Atmung, 2026;30(4)
Chronic semaglutide alters ingestive behavior without impairing taste function in mice
Molecular metabolism, 2026;:102410
Secondary alopecia due to semaglutide
Medicina clinica, 2026;166(9):107507
Papular granuloma annulare associated with tirzepatide: A case report
JAAD case reports, 2026;74:225-227
Adult Annular Pancreas Presenting With Gastric Outlet Obstruction Following Semaglutide Initiation: A Case Report
Cureus, 2026;18(6):e111636
From dual to quintuple agonism for next-generation pharmacology to treat obesity and type 2 diabetes: synergistic incretin and nuclear receptor signaling
Cardiovascular diabetology. Endocrinology reports, 2026;12(1)
GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Propensity Score-Matched Real-World Analysis
Respiratory medicine, 2026;:109001